INT313909

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Abstract
Documents 1
Total Number 1
Disease Relevance 0.91
Pain Relevance 0.32

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

translation (Eif3h) protein complex (Eif3h) cytoplasm (Eif3h)
Eif3h (Mus musculus)
Pain Link Frequency Relevance Heat
psoriasis 92 98.52 Very High Very High Very High
Etanercept 10 65.76 Quite High
cytokine 12 5.00 Very Low Very Low Very Low
Arthritis 9 5.00 Very Low Very Low Very Low
antagonist 6 5.00 Very Low Very Low Very Low
Inflammation 5 5.00 Very Low Very Low Very Low
withdrawal 3 5.00 Very Low Very Low Very Low
topical agent 2 5.00 Very Low Very Low Very Low
Infliximab 2 5.00 Very Low Very Low Very Low
methotrexate 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Psoriasis 103 98.52 Very High Very High Very High
Disease 20 94.76 High High
Infection 6 82.12 Quite High
Nicotine Addiction 4 81.52 Quite High
Skin Diseases 3 76.08 Quite High
Seronegative Spondarthritis 6 5.00 Very Low Very Low Very Low
Cancer 5 5.00 Very Low Very Low Very Low
INFLAMMATION 5 5.00 Very Low Very Low Very Low
Arthritis 4 5.00 Very Low Very Low Very Low
Obesity 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Ustekinumab, a monoclonal antibody targeting the p40 subunit of interleukin (IL)-12 and IL-23, is one such new agent.
Regulation (targeting) of p40 subunit
1) Confidence 0.01 Published 2010 Journal Biologics : Targets & Therapy Section Abstract Doc Link PMC2880344 Disease Relevance 0.91 Pain Relevance 0.32

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox